Choreo LLC Has $4.29 Million Stock Holdings in MetLife, Inc. (NYSE:MET)

Choreo LLC lessened its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 15.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,413 shares of the financial services provider's stock after selling 9,682 shares during the quarter. Choreo LLC's holdings in MetLife were worth $4,289,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Ball & Co Wealth Management Inc. acquired a new stake in MetLife in the fourth quarter valued at $25,000. Transce3nd LLC acquired a new stake in MetLife in the fourth quarter valued at $26,000. North Capital Inc. acquired a new stake in MetLife in the first quarter valued at $26,000. Quarry LP acquired a new stake in MetLife in the fourth quarter valued at $31,000. Finally, Graney & King LLC acquired a new stake in MetLife in the fourth quarter valued at $34,000. Institutional investors and hedge funds own 94.99% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on MET shares. Morgan Stanley decreased their price objective on MetLife from $99.00 to $98.00 and set an "overweight" rating on the stock in a research note on Monday, July 14th. Barclays raised their price objective on MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a research note on Monday, July 7th. Wells Fargo & Company reiterated an "overweight" rating and set a $97.00 target price (up previously from $94.00) on shares of MetLife in a research note on Thursday, July 10th. Keefe, Bruyette & Woods reduced their price objective on MetLife from $95.00 to $94.00 and set an "outperform" rating for the company in a research report on Wednesday, July 9th. Finally, Piper Sandler lifted their target price on MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $96.09.

MetLife Stock Up 0.7%

Shares of MET stock traded up $0.55 on Friday, reaching $78.34. 1,065,480 shares of the company's stock traded hands, compared to its average volume of 3,355,790. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market capitalization of $52.59 billion, a P/E ratio of 12.73, a price-to-earnings-growth ratio of 0.64 and a beta of 0.85. The business's 50 day moving average price is $78.72 and its two-hundred day moving average price is $79.72.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing analysts' consensus estimates of $2.00 by ($0.04). MetLife had a net margin of 6.08% and a return on equity of 20.89%. The firm had revenue of $18.57 billion during the quarter, compared to analysts' expectations of $18.06 billion. During the same quarter last year, the firm earned $1.83 EPS. The business's revenue for the quarter was up 15.6% compared to the same quarter last year. On average, equities analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be paid a $0.5675 dividend. The ex-dividend date is Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a yield of 2.90%. MetLife's dividend payout ratio (DPR) is currently 36.91%.

MetLife declared that its Board of Directors has approved a share repurchase plan on Wednesday, April 30th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.